Observational studyArthritis research & therapy2016

A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study.

Martin H Stradner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.